Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd, Nagoya, 462-0024 Japan, Marketed by Kowa Pharmaceuticals: Kowa Pharmaceuticals America Inc., Montgomery, AL 36117 USA NDC 66869-404-90 HDPE Bottle, congregated into a shrink wrapped 6-pack further congregated into 24 6-packs in a cardboard case
Published March 19, 2025 · Recall initiated: February 24, 2025
Summary
FDA records drug Class III recall D-0258-2025, published March 19, 2025 and initiated February 24, 2025. Recalling firm: Kowa Pharmaceuticals America; Status: Completed; Reported quantity: 5,328 Bottles; Lot: Lot#: 3231300, Exp 8/2027. Class III means the product is not likely to cause adverse health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign tablets/capsules
What to do
Voluntary: Firm initiated
Get an email if LIVALO has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LIVALO
- Manufacturer
- Kowa Pharmaceuticals America
- Distributor
- PA, OH, and TX
- UPC
- 0366869204905
- Lot
- Lot#: 3231300, Exp 8/2027
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility,March 19, 2025
- FDABD ChloraPrep Clear 1mL Applicators, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA),March 19, 2025
- FDABimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finallyMarch 19, 2025
- FDABD BBL TB Stain Kit K, Catalog (REF): 212522March 12, 2025
- FDAVios Monitoring System Bedside Monitor Model BSM2050March 12, 2025
- FDALivalo (pitavastatin) tablets 2 mg* Rx Only NdC 66869-204-90 Manufactured under license from: Kowa Company,June 2, 2021
Questions about this recall
Was Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd, Nagoya, 462-0024 Japan, Marketed by Kowa Pharmaceuticals: Kowa Pharmaceuticals America Inc., Montgomery, AL 36117 USA NDC 66869-404-90 HDPE Bottle, congregated into a shrink wrapped 6-pack further congregated into 24 6-packs in a cardboard case recalled?
Yes. FDA published recall D-0258-2025 on March 19, 2025. Reported hazard: Presence of foreign tablets/capsules
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LIVALO. UPC: 0366869204905.